Next Article in Journal
Innate Immune Responses to Influenza Virus Infections in the Upper Respiratory Tract
Next Article in Special Issue
Clusters of SARS-CoV-2 Lineage B.1.1.7 Infection after Vaccination with Adenovirus-Vectored and Inactivated Vaccines
Previous Article in Journal
Nonhuman Primate Models of Zika Virus Infection and Disease during Pregnancy
Previous Article in Special Issue
Imbalanced Immune Response of T-Cell and B-Cell Subsets in Patients with Moderate and Severe COVID-19
 
 
Communication
Peer-Review Record

Viral Shedding among Re-Positive Severe Acute Respiratory Syndrome Coronavirus-2 Positive Individuals in Republic of Korea

Viruses 2021, 13(10), 2089; https://doi.org/10.3390/v13102089
by Jeong-Min Kim 1,†, Boyeong Ryu 2,†, Young June Choe 3, Hye-Jun Jo 1, Hyeokjin Lee 1, Heui Man Kim 1, Nam-Joo Lee 1, Jee Eun Rhee 1, Yoon-Seok Chung 4, Myung-Guk Han 5, Eun-Jin Kim 1, Youngjoon Park 6, Jin Gwack 7, Yeowon Jin 7, Jeongsuk Song 8, Seunghee Seo 9, Byoungchul Gill 10, Hyunyeong Kim 9, Yeeun Park 9, Cheon Kwon Yoo 11 and Eun Kyeong Jeong 12,*add Show full author list remove Hide full author list
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Viruses 2021, 13(10), 2089; https://doi.org/10.3390/v13102089
Submission received: 30 July 2021 / Revised: 27 September 2021 / Accepted: 13 October 2021 / Published: 17 October 2021
(This article belongs to the Collection SARS-CoV-2 and COVID-19)

Round 1

Reviewer 1 Report

Thank you for this work. It will add usefully to the literature. A few comments follow.

  • People are not infectious, pathogens are. Please be mindful of syntax regarding infectivity. For instance, the first sentence of the abstract could be adjusted to, "This study investigated the viral burden in secretions of individuals with coronavirus disease who re-tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA after recovering from their primary illness." Please make this or a similar adjustment through-out. For instance, it happens again on lines 58 and 78.
  • I am struggling to understand a syntax versus semantic issue, in part because you used the phrase primary infection rather than primary illness. When you say recurrence, are you asserting that they (1) have become infected again from a new exposure, (2) have recrudescent disease, or (3) either? Those within 30-45 days or with concomitant illnesses are quite reasonable for (2) and those greater than 45 days are suggestive of (1) > (2). This has implications for your premise/ structure and analysis and should be clarified, analyses adjusted.
  • It is possible that one of the reasons observed attack rate of household contacts was low was because they had COVID-19 commensurate with the enrolled cases' primary illnesses. It appears that you only assessed neutralizing Ab on those contacts who were +?
  • What were the cycle times of the cases purportedly sources of household contact infections? 

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

1. Is there possibility that recurrent positive cases were missed? or all recovered cases were re-tested? 2. Possibility of transmission of infection via SARS-CoV2 viruses in stool if the individuals with re-infection detected stool PCR positivity? 3. Apart from diagnostic stewardship, any recommendations from this study generated? e.g. re-infection patients isolation requirement? 4. Any difference in the conclusion in era of SARS-CoV2 variants?

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop